Literature DB >> 31053970

Macrophage derived TNFα promotes hepatic reprogramming to Warburg-like metabolism.

Tatyana N Tarasenko1, Maxim Jestin1, Shingo Matsumoto2, Keita Saito3, Sean Hwang1, Oksana Gavrilova4, Niraj Trivedi5, Patricia M Zerfas6, Emanuele Barca7, Salvatore DiMauro7, Julien Senac1, Charles P Venditti1, Murali Cherukuri3, Peter J McGuire8.   

Abstract

During infection, hepatocytes must undergo a reprioritization of metabolism, termed metabolic reprogramming. Hepatic metabolic reprogramming in response to infection begins within hours of infection, suggesting a mechanism closely linked to pathogen recognition. Following injection with polyinosinic:polycytidylic acid, a mimic of viral infection, a robust hepatic innate immune response could be seen involving the TNFα pathway at 2 h. Repeated doses led to the adoption of Warburg-like metabolism in the liver as determined by in vivo metabolic imaging, expression analyses, and metabolomics. Hepatic macrophages, Kupffer cells, were able to induce Warburg-like metabolism in hepatocytes in vitro via TNFα. Eliminating macrophages in vivo or blocking TNFα in vitro or in vivo resulted in abrogation of the metabolic phenotype, establishing an immune-metabolic axis in hepatic metabolic reprogramming. Overall, we suggest that macrophages, as early sensors of pathogens, instruct hepatocytes via TNFα to undergo metabolic reprogramming to cope with challenges to homeostasis initiated by infection. This work not only addresses a key component of end-organ physiology, but also raises questions about the side effects of biologics in the treatment of inflammatory diseases. KEY MESSAGES: • Hepatocytes develop Warburg-like metabolism in vivo during viral infection. • Macrophage TNFα promotes expression of glycolytic enzymes in hepatocytes. • Blocking this immune-metabolic axis abrogates Warburg-like metabolism in the liver. • Implications for patients being treated for inflammatory diseases with biologics.

Entities:  

Keywords:  Cytokines; Hepatocytes; Immunometabolism; Macrophages; Metabolic reprogramming; Tumor necrosis factor alpha; Warburg-like metabolism

Mesh:

Substances:

Year:  2019        PMID: 31053970      PMCID: PMC6715514          DOI: 10.1007/s00109-019-01786-w

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  51 in total

Review 1.  Innate immunity.

Authors:  R Medzhitov; C Janeway
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

Review 2.  Metabolic response to infection.

Authors:  W R Beisel
Journal:  Annu Rev Med       Date:  1975       Impact factor: 13.739

Review 3.  Hepatic response to sepsis: interaction between coagulation and inflammatory processes.

Authors:  J F Dhainaut; N Marin; A Mignon; C Vinsonneau
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

4.  Hypothermia in mice due to influenza virus infection.

Authors:  Y T YANG; C A EVANS
Journal:  Proc Soc Exp Biol Med       Date:  1961-12

5.  Evaluation of an in vitro model of hepatic inflammatory response by gene expression profiling.

Authors:  Arul Jayaraman; Martin L Yarmush; Charles M Roth
Journal:  Tissue Eng       Date:  2005 Jan-Feb

Review 6.  The liver as an immunological organ.

Authors:  Vito Racanelli; Barbara Rehermann
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 7.  Influenza viremia and the potential for blood-borne transmission.

Authors:  Anna M Likos; David J Kelvin; Cheryl M Cameron; Thomas Rowe; Matthew J Kuehnert; Philip J Norris
Journal:  Transfusion       Date:  2007-06       Impact factor: 3.157

8.  Cytokines contribute to early hepatic parenchymal injury and microvascular dysfunction after bilateral hindlimb ischemia.

Authors:  D K Lawlor; R W Brock; K A Harris; R F Potter
Journal:  J Vasc Surg       Date:  1999-09       Impact factor: 4.268

9.  cDNA microarray analysis of HBV transgenic mouse liver identifies genes in lipid biosynthetic and growth control pathways affected by HBV.

Authors:  Mustapha Hajjou; Raquel Norel; Robert Carver; Patricia Marion; John Cullen; Leslie E Rogler; Charles E Rogler
Journal:  J Med Virol       Date:  2005-09       Impact factor: 2.327

10.  Long-term stable cultures of rat hepatocytes: an in vitro model to study acute and chronic hepatic inflammation.

Authors:  Yoon H Kang; François Berthiaume; Martin L Yarmush
Journal:  Tissue Eng       Date:  2002-08
View more
  5 in total

1.  Rewiring of immune-metabolic crosstalk in the liver after viral infection.

Authors:  Kyra E de Goede; Jan Van den Bossche
Journal:  J Mol Med (Berl)       Date:  2019-08-01       Impact factor: 4.599

Review 2.  A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight.

Authors:  Christine R Cuthbertson; Zahra Arabzada; Armand Bankhead; Armita Kyani; Nouri Neamati
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-01

3.  Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity.

Authors:  Maxim Jestin; Senta M Kapnick; Tatyana N Tarasenko; Cassidy T Burke; Patricia M Zerfas; Francisca Diaz; Hilary Vernon; Larry N Singh; Ronald J Sokol; Peter J McGuire
Journal:  Mol Metab       Date:  2020-03-26       Impact factor: 7.422

Review 4.  Hallmarks of Metabolic Reprogramming and Their Role in Viral Pathogenesis.

Authors:  Charles N S Allen; Sterling P Arjona; Maryline Santerre; Bassel E Sawaya
Journal:  Viruses       Date:  2022-03-14       Impact factor: 5.048

Review 5.  Hyperpolarized 13C Magnetic Resonance Imaging as a Tool for Imaging Tissue Redox State, Oxidative Stress, Inflammation, and Cellular Metabolism.

Authors:  Neil J Stewart; Tatsuyuki Sato; Norihiko Takeda; Hiroshi Hirata; Shingo Matsumoto
Journal:  Antioxid Redox Signal       Date:  2021-08-17       Impact factor: 8.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.